Global Healthcare Leader to Separate from Tyco International
MANSFIELD, Mass., June 14 /PRNewswire-FirstCall/ -- Tyco Healthcare
will participate in a meeting, held on June 19, 2007 and hosted by Tyco
International, to update the investment community on the planned June 29,
2007, separation of Tyco International, Tyco Electronics and Tyco
Healthcare into three independent, publicly traded companies.
Tyco Healthcare will become Covidien (NYSE: COV, BSX: COV) and will
begin independent trading on the New York and Bermuda Stock Exchanges on
July 2, 2007, marking its debut as an independent diversified global
healthcare products company.
The investor meeting will include presentations from Edward Breen,
Chairman and CEO of Tyco International; Thomas Lynch, CEO of Tyco
Electronics; Richard Meelia, President and CEO of Tyco Healthcare
(Covidien); and select members of their management teams. Members of the
media are invited to attend. The presentation on Covidien will begin at 2
p.m., followed by a question and answer session.
TYCO INVESTOR MEETING
Tuesday, June 19, 2007
8 a.m. -- 4 p.m.
Equitable Center Auditorium
787 Seventh Avenue (between 51st and 52nd Streets)
New York City
Tyco will be providing a media room which will be located in the
Equitable Center. The media room will carry a closed-circuit telecast of
the meeting and will be equipped with high-speed internet connections and
telephones. The press room will open at 7:30 a.m. and light refreshments
will be available.
Individuals who are unable to attend the meeting in person will be able
to participate in a live webcast via Tyco's corporate website http://www.tyco.com.
Please confirm your attendance with David T. Young, 508-261-6330 or
david.young@tycohealthcare.com
ABOUT COVIDIEN
Covidien is a leading global healthcare products company that creates
innovative medical solutions for better patient outcomes and delivers value
through clinical leadership and excellence. Covidien manufactures,
distributes and services a diverse range of industry-leading product lines,
including surgical devices, energy-based devices, respiratory and
monitoring solutions, pharmaceutical products, imaging solutions, patient
care and safety products, and medical supplies. With 2006 revenue of nearly
$10 billion, Covidien has more than 43,000 employees worldwide in 57
countries, and its products are sold in over 130 countries. Please visit
http://www.covidien.com to learn more about our business.
SOURCE Tyco Healthcare
 back to top
Related links:
http://www.tyco.com
http://www.covidien.com
CONTACT:
Eric Kraus, Senior Vice President, Corporate
Communications, +1-508-261-8305, eric.kraus@tycohealthcare.com;
or Cole Lannum, Vice President, Investor Relations,
+1-508-452-4343, cole.lannum@tycohealthcare.com; or Bruce Farmer,
Director, Financial Communications, +1-508-452-4372,
bruce.farmer@tycohealthcare.com; or Wayde McMillan, Director,
Investor Relations, +1-508-452-4387,
wayde.mcmillan@tycohealthcare.com, all of Tyco Healthcare
|
